NEFL and myeloid sarcoma: They stated that pNfL cannot be used as a biomarker of cognitive function in patients with stable MS [48], although the data are conflicting because Mattioli et al. found a correlation between NfL and cognitive function and expressed the possibility of using NfL as a biological marker of cognitive dysfunction in MS patients.